CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


22-December-2010
Cerilliant Introduces the First Certified Spiking Solution® of the Primary Urinary Metabolite of Tapentadol (Tapentadol-ß-D-glucuronide)

Tapentadol-ß-D-glucuronide, T-060
100 ug/mL in 1:1 Acetonitrile:Water

The first Certified Spiking Solution® of the primary urinary metabolite of tapentadol. Tapentadol is the first new drug of the centrally-acting analgesic class approved in the US for pain management in more than 25 years. This new Certified Spiking Solution® is suitable for many LC/MS or GC/MS applications, including pain prescription monitoring, forensic testing, clinical toxicology, or urine drug testing.

In addition to the glucuronide, we offer Certified Spiking Solutions® of tapentadol (T-058), its stable-labeled internal standard (T-059), and the sulfate (T-061) and N-desmethyl metabolites (D-052).


Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO 17034 and ISO/IEC 17025 & certified ISO 9001.


All New Product Announcements


© 2024 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact